ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Breast Asymmetry Predicts Breast Cancer, Study Finds

March 31, 2006

NCI advisors approve $144 million program for nanotechnology centers, R01 grants, training. Three to five consortia envisioned.

July 16, 2004

Hamburg Confirmed As FDA Commissioner

May 22, 2009

The Selling Begins: CT Offered Beyond High-Risk Group

November 26, 2010

In Brief: Philadelphia Chromosome Discoverer Hungerford Dead; Oregon Recruits Scientists

November 12, 1993

HHS Back down, Says Now It Will Support Survey Of Research Facilities

October 28, 1983